SEC Form 4 · accession 0001127602-16-054799
CONMED Corp · CNMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Luke A Pomilio
Officer — EVP, Finance & CFO
Period of report
Jun 3, 2016
Accepted (ET)
Jun 6, 2016 · 1:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 3, 2016 | M | 10,000 | $29.92 | A | 41,884 | D | |
| Common StockF1 | Jun 3, 2016 | S | 4,400 | $41.5638 | D | 37,484 | D | |
| Common Stock | Jun 3, 2016 | M | 10,000 | $26.69 | A | 47,484 | D | |
| Common Stock | Jun 3, 2016 | F | 1,794 | $41.83 | D | 45,690 | D | |
| Common Stock | Jun 3, 2016 | F | 2,280 | $41.83 | D | 43,410 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sars (Stock Appreciation Rights)F2 | $29.92 | Jun 3, 2016 | M | 10,000 | D | May 17, 2008 | May 17, 2017 | Common Stock | 10,000 | 0 | D |
| Sars (Stock Appreciation Rights)F2 | $26.69 | Jun 3, 2016 | M | 10,000 | D | Jun 1, 2009 | Jun 1, 2018 | Common Stock | 10,000 | 0 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.53 to $41.62. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder."
- F2The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal amounts over a five year period.